Uniting the Precision Medicine Ecosystem to Improve Care for Cancer Patients

For almost nine months, I have been proud to lead Syapse in our mission to deliver the best care for every cancer patient through precision…

kentarkoff

By Ken Tarkoff

11/13/2017

New Survey: Precision Medicine is Rapidly Becoming a Top Priority for Leading Health Systems

Health systems want to deliver the most innovative, effective cancer care to their patients and more and more of them are realizing the potential of precision medicine.

Read

Why We Need More Data Sharing in Cancer Care

The Washington Post published a story this weekend that sums up why I am so excited about the future of precision medicine. The article…

Read

Three Challenges Precision Medicine Has to Overcome

Thirteen years ago, my father sat me down for the hardest conversation of my life. He told me that he had been diagnosed with Stage 4 colon…

Read

A Statement from Syapse in Support of the 21st Century Cures Act

Syapse is excited and encouraged by the passage of the 21st Century Cures Act. The continued funding of the Cancer Moonshot and Precision Me…

Read

Jonathan Hirsch Featured in VP Biden's Cancer Moonshot Video

Watch Vice President Joe Biden and Cancer Moonshot participants discuss the need for fundamental changes in the fight to end cancer. Jonatha…

Read

PMWC16 Panel: Clinical Implementation of Precision Medicine Programs

Want to understand how healthcare systems and payers are approaching precision medicine? Watch this video of Syapse Founder & President Jona…

Read

AWS Interview with Jason Gillman of Intermountain Precision Genomics

Learn from Jason Gillman and Jonathan Hirsch about how Intermountain leveraged Syapse, running on Amazon Web Services, to address the e…

Read

Oliver Wyman Executive Conversation with Jonathan Hirsch

Jonathan Hirsch recently teamed up with Oliver Wyman Associate Terrance Wallace to discuss the use of precision medicine to revolutionize cl…

Read

Improving Accrual Rates with the Syapse Clinical Trials Matching Feature

According to the American Cancer Society, “Fewer than 5% of adults (less than 1 in 20) with cancer will take part in a clinical trial&h…

Read

GuideWell Interview with Jonathan Hirsch at Oliver Wyman

On October 13th, Jonathan Hirsch sat with GuideWell’s Kate Warnock at the 2015 Oliver Wyman Health Innovation Summit to discuss what is need…

Read

A Blueprint for Precision Medicine at Swedish Cancer Institute

As community health systems adopt precision medicine, providing a roadmap for implementation of a precision medicine program is a key part o…

Read

Syapse Joins International Leaders in Precision Medicine in Support of the Manhattan Institute's Project FDA

Syapse is proud to join leaders in the fields of precision medicine and public policy in support of the Manhattan Institute’s Project F…

Read

UCSF Partners with Syapse to Tackle Infectious Disease

We’re excited to be working with UCSF to extend the reach of precision medicine beyond cancer and into pathogen detection. Each ye…

Read

How Syapse Puts the "Action" into Clinically Actionable Genomic Data

A leading cancer center estimates that “currently only 10% to 20% of patients with actionable mutations actually end up on a [targeted] drug…

Read

Video of PMWC 2015 panel, "Genomic Profiling Moving Into Routine Clinical Care" available!

Earlier this year at the Personalized Medicine World Conference 2015 in Silicon Valley, Founder & President Jonathan Hirsch moderated the pa…

Read

AWS re:Invent video and slides now available!

In case you weren’t able to see it in person, Jonathan Hirsch’s recent talk with Kristen McCaleb of UCSF and Nate Slater of AWS at AWS

Read

Syapse Named as Innovation Showcase Finalist at HealthBeat 2014

We were very proud to be named as a finalist for HealthBeat 2014’s Innovation Showcase. In VentureBeat’s words:”Spurred…

Read

Syapse at Health 2.0

See Jonathan Hirsch’s short but sweet demo at this year’s Health 2.0 Conference. (Note: Jonathan Hirsch is the Founder & President of…

Read